Extrait

Efficacy and safety of a triptorelin 6-month formulation in patients with advanced prostate cancer. It was assumed that during the study treatment >90% of the patients would achieve and maintain castrate levels of serum testosterone.

Critère d'inclusion

• Prostatic Neoplasm

Liens

• ictrp
• nct